Once you’ve moved into Phase II, the likelihood that your drug will be approved begins to increase substantially. Because of this, it’s a vital time to start investing resources in your go to market strategy. Hence, at Phase II we begin to dig deeper into our research, focusing on what’s going to be needed to launch and sell the new drug, as well as beginning to plan pricing and market access strategies.
At Two Labs, we have a vast network of key opinion leaders, including MDs, academics, nurses, pharmacists, and sales experts, which we can leverage to give you the insight needed to move forward with confidence.
To maximize your revenue, it’s vital that you develop proper strategy that takes payers, physicians and patients into consideration.
Gaining a thorough understanding of the market, as well as the future environment, is critical for sound decision making.
To understand the pricing and market access potential for new treatments, clients need to hear from KOLs and payers. At Two Labs, we conduct blinded and unblinded panels, depending on your needs.
Increase your awareness of your drug’s disease landscape and competitor activities to determine how to differentiate your drug in the market to be successful.
Save time and money without losing out on important developments in the pharma world with our full medical congress coverage services.
Understand what physicians and patients want to see from your new product with our in-depth primary source interviewing services.
Gain the most from your benchmarking study with our key insights, complete with an action list and detailed recommendations.
We help optimize your launch strategy by analyzing what worked and didn’t work for similar drugs so you can properly develop a successful launch strategy.
Our Competitive Simulations are your key to deeper competitor insight and a smarter business development strategy.
